ImmunoPrecise Antibodies (IPA) News Today $0.47 +0.01 (+2.85%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$0.47 +0.00 (+0.60%) As of 01/31/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Top 10 AI Stocks Dominating Wall StreetJanuary 27, 2025 | msn.comImmunoPrecise Antibodies Ltd. (IPA) Unveils AI-Developed GLP-1 Therapies for Type 2 Diabetes and Obesity, Pioneering New Frontiers in Biotech InnovationJanuary 27, 2025 | msn.comImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville DebentureJanuary 27, 2025 | businesswire.comImmunoPrecise Antibodies Target of Unusually Large Options Trading (NASDAQ:IPA)January 23, 2025 | americanbankingnews.comThis Biotech Soared On Wednesday Following AI-Related AnnouncementJanuary 22, 2025 | msn.comIPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes TreatmentJanuary 22, 2025 | businesswire.comImmunoPrecise Antibodies Ltd. (IPA) Launches AI-Powered Drug Discovery Pipeline, Revolutionizing Therapeutic Development with LENSai™ PlatformJanuary 20, 2025 | insidermonkey.comImmunoPrecise Antibodies Launches AI-Powered Drug Discovery PlatformJanuary 17, 2025 | tipranks.comImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles InnovationJanuary 17, 2025 | financialpost.comImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles InnovationJanuary 17, 2025 | financialpost.comImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles InnovationJanuary 17, 2025 | businesswire.comImmunoPrecise Antibodies finance chief to step downJanuary 2, 2025 | msn.comImmunoPrecise Antibodies CFO Kristin Taylor To ResignJanuary 1, 2025 | markets.businessinsider.comImmunoPrecise Antibodies announces resignation of CFOJanuary 1, 2025 | markets.businessinsider.comImmunoPrecise Antibodies CFO Resignation and SuccessionDecember 31, 2024 | tipranks.comIPA Announces Resignation of Chief Financial OfficerDecember 31, 2024 | businesswire.com$116 Million Multifamily Asset Sale in Central California Coast Region Brokered by Marcus & Millichap's Institutional Property AdvisorsDecember 30, 2024 | businesswire.comImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share PurchasesDecember 23, 2024 | businesswire.comImmunoPrecise Antibodies to Showcase at Microcap ConferenceDecember 19, 2024 | tipranks.comImmunoPrecise Antibodies Reports Q2 Results and Strategic Advances in AI-Driven Drug DiscoveryDecember 11, 2024 | markets.businessinsider.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call TranscriptDecember 11, 2024 | msn.comImmunoPrecise Antibodies Ltd. (IPA) Q2 2025 Earnings Call TranscriptDecember 10, 2024 | seekingalpha.comImmunoPrecise Antibodies Ltd.December 5, 2024 | thestreet.comImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics InnovationNovember 4, 2024 | businesswire.comImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI TechnologyOctober 28, 2024 | businesswire.comInstitutional Property Advisors Brokers $92.5 Million Multifamily Sale in L.A.'s NoHo Arts DistrictOctober 16, 2024 | businesswire.comImmunoPrecise Antibodies earnings preview: what Wall Street is expectingSeptember 15, 2024 | markets.businessinsider.comImmunoprecise Antibodies Ltd MediaAugust 27, 2024 | lse.co.ukImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New YorkAugust 26, 2024 | businesswire.comImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid RequirementsAugust 23, 2024 | businesswire.comImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024July 29, 2024 | financialpost.comImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024July 23, 2024 | financialpost.comImmunoPrecise Appoints Kristin Taylor as Chief Financial OfficerJune 27, 2024 | financialpost.comIPA's Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™June 25, 2024 | businesswire.comImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ TechnologyJune 12, 2024 | businesswire.comBioStrand, ImmunoPrecise Antibodies' Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug DiscoveryJune 10, 2024 | businesswire.comIPA's Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR)June 4, 2024 | businesswire.comImmunoPrecise Antibodies Ltd. (IPA)April 26, 2024 | finance.yahoo.comInterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare ApplicationsMarch 28, 2024 | finance.yahoo.comInterSystems and IPA's Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare ApplicationsMarch 28, 2024 | businesswire.comIPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI DevelopmentsMarch 20, 2024 | businesswire.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2024 Earnings Call TranscriptMarch 15, 2024 | msn.comIPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024March 14, 2024 | investorplace.comIPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT TechnologyMarch 7, 2024 | finance.yahoo.comIPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT TechnologyMarch 7, 2024 | businesswire.comIPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024March 4, 2024 | finance.yahoo.comImmunoPrecise Antibodies (NASDAQ:IPA) Shares Down 2.3% ImmunoPrecise Antibodies (NASDAQ:IPA) Trading Down 2.3%February 10, 2024 | marketbeat.comBuy Rating on ImmunoPrecise Antibodies Reflects Strong Revenue Growth and Cost Management SuccessDecember 16, 2023 | markets.businessinsider.comIPA Announces Closing of $1.265 Million Public Offering of Common SharesDecember 8, 2023 | finance.yahoo.comWhy ImmunoPrecise Antibodies (IPA) Stock Is Down 20% TodayDecember 6, 2023 | benzinga.com Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address IPA Media Mentions By Week IPA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPA News Sentiment▼0.320.70▲Average Medical News Sentiment IPA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPA Articles This Week▼40▲IPA Articles Average Week Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Annovis Bio News Mural Oncology News BeyondSpring News OptiNose News IO Biotech News Prelude Therapeutics News Kronos Bio News ZIVO Bioscience News Reviva Pharmaceuticals News PepGen News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IPA) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
